| Action | Key |
|---|---|
| Play / Pause | K or space |
| Mute / Unmute | M |
| Select next subtitles | C |
| Select next audio track | A |
| Show slide in full page or toggle automatic source change | V |
| Seek 5s backward | left arrow |
| Seek 5s forward | right arrow |
| Seek 10s backward | shift + left arrow or J |
| Seek 10s forward | shift + right arrow or L |
| Seek 60s backward | control + left arrow |
| Seek 60s forward | control + right arrow |
| Decrease volume | shift + down arrow |
| Increase volume | shift + up arrow |
| Decrease playback rate | shift + comma |
| Increase playback rate | shift + dot or shift + semicolon |
| Seek to end | end |
| Seek to beginning | beginning |
Share this media
Download links
HLS video stream
You can use an external player to play this stream (like VLC).
HLS video streamInformation on this media
Hélène Eltchaninoff, membre de la Fédération Hospitalo-Universitaire
Hélène Eltchaninoff, Chef de Service de Cardiologie au CHU de Rouen, a mené ses travaux de recherche dans le domaine du traitement percutané des valvulopathies, thème phare du service. Elle a implanté avec Alain Cribier la première valve aortique percutanée au monde en avril 2002.
Elle anime depuis un an la Fédération Hospitalo-Universitaire (FHU) REMOD-VHF qui rassemble des partenaires Hospitaliers des CHU de Rouen, Amiens, Caen et Lille, ainsi que 3 Unités Inserm, un centre CNRS et une équipe d’accueil Universitaire autour de l‘endothélium, des valvulopathies et de l’insuffisance cardiaque.
La labellisation FHU a permis de répondre à l’appel d’offre national Recherche Hospitalo-Universitaire en santé (RHU) lancé par l’Agence Nationale pour la Recherche (ANR) dans le cadre d’un grand programme d’investissement d’avenir très compétitif. Un projet très ambitieux centré sur le rétrécissement aortique STOP AS (Search Treatment and improve Outcome of Patients with Aortic Stenosis) a été déposé en février 2016.
Hélène Eltchaninoff, Head of the Department of Cardiology at the University Hospital of Rouen, has conducted her research in the field of percutaneous treatment of valvular heart disease, flagship theme of the department. She implanted with Alain Cribier the first worldwide percutaneous aortic valve in April 2002.
She coordinates since one year the University Hospital Federation (FHU) REMOD-VHF that brings together partners from 4 University Hospitals (Rouen, Amiens, Caen and Lille), 3 INSERM Units, 1 CNRS center and 1 University Host Team around endothelium, valvular heart disease and heart failure thematics.
The FHU labeling allowed her to respond to the National call of projects “University Hospital Research” (RHU) launched by the National Research Agency (ANR) as part of a highly competitive great future investment program. A very ambitious project, named STOP-AS (Search Improve Treatment and Outcome of Patients with Aortic Stenosis), focused on aortic stenosis was submitted in February 2016.
From the same channel
149 views, 3 this yearAngela VELLA IUFMarch 23rd, 2017
435 views, 12 this yearFabrice Duparc, programme IDEFI : REMIS Table anatomiqueMay 4th, 2016
92 views, 2 this yearChristine Heuclin et Guillaume Legent, co-fondateurs de BiosimsMay 4th, 2016
118 views, 5 this yearEstelle Louiset, prix de recherche de la Société Française d'EndocrinologieMay 4th, 2016
63 views, 1 this yearXavier Pannecoucke, Coordonnateur du Labex SynOrgMay 4th, 2016
198 views, 6 this yearPhilippe Pareige, projet EQUIPEX : GENESISMay 4th, 2016
When subscribed to notifications, an email will be sent to you for all added annotations.
Your user account has no email address.